Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000053417-26-000007·Arcutis Biotherapeutics, Inc.
Schedule 13G ownership disclosure
Arcutis Biotherapeutics Inc
Common Stock · CUSIP: 03969K108
Event date: 2025-12-31
- Filing-level shares
- 6,758,006
- Percent of class
- 5.5%
- Jennison Associates LLC
Shares: 6,758,006 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000053417-26-000007
- Form type
- SCHEDULE 13G/A
- Filer
- Arcutis Biotherapeutics, Inc.
- CIK
- CIK 1787306
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership